methadone has been researched along with Allodynia in 36 studies
Methadone: A synthetic opioid that is used as the hydrochloride. It is an opioid analgesic that is primarily a mu-opioid agonist. It has actions and uses similar to those of MORPHINE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1082-3)
methadone : A racemate comprising equimolar amounts of dextromethadone and levomethadone. It is a opioid analgesic which is used as a painkiller and as a substitute for heroin in the treatment of heroin addiction.
6-(dimethylamino)-4,4-diphenylheptan-3-one : A ketone that is heptan-3-one substituted by a dimethylamino group at position 6 and two phenyl groups at position 4.
Excerpt | Relevance | Reference |
---|---|---|
"Using a prospective, randomized, blinded design, adolescents presenting for posterior spinal fusion to treat idiopathic scoliosis were assigned to receive desflurane with remifentanil alone (REMI), remifentanil + methadone (MET) (0." | 9.27 | Analgesic effects of methadone and magnesium following posterior spinal fusion for idiopathic scoliosis in adolescents: a randomized controlled trial. ( Barry, N; Beebe, AC; Bhalla, T; Gill, L; Klamar, J; Martin, DP; Rice, J; Samora, WP; Thung, A; Tobias, JD; Tumin, D; Veneziano, G, 2018) |
"The reports on pain perception among former heroin addicts receiving methadone maintenance treatment (MMT) vary with regard to pain and intolerance threshold, and perception of suprathreshold stimuli has not been previously evaluated." | 7.77 | The differential effect of methadone dose and of chronic pain on pain perception of former heroin addicts receiving methadone maintenance treatment. ( Adelson, M; Defrin, R; Hetzroni, T; Peles, E; Schreiber, S, 2011) |
"Using a prospective, randomized, blinded design, adolescents presenting for posterior spinal fusion to treat idiopathic scoliosis were assigned to receive desflurane with remifentanil alone (REMI), remifentanil + methadone (MET) (0." | 5.27 | Analgesic effects of methadone and magnesium following posterior spinal fusion for idiopathic scoliosis in adolescents: a randomized controlled trial. ( Barry, N; Beebe, AC; Bhalla, T; Gill, L; Klamar, J; Martin, DP; Rice, J; Samora, WP; Thung, A; Tobias, JD; Tumin, D; Veneziano, G, 2018) |
"Antinociceptive effect of narcotic analgesics, fentanyl, oxycodone and methadone in inflammatory pain state was described in the von Frey filament test using the complete Freund's adjuvant (CFA)-induced mouse inflammatory pain model." | 3.80 | Differential alternation of the antinociceptive effect of narcotic analgesics on the inflammatory pain state. ( Aoki, Y; Mizoguchi, H; Sakurada, S; Sakurada, T; Watanabe, C, 2014) |
"The reports on pain perception among former heroin addicts receiving methadone maintenance treatment (MMT) vary with regard to pain and intolerance threshold, and perception of suprathreshold stimuli has not been previously evaluated." | 3.77 | The differential effect of methadone dose and of chronic pain on pain perception of former heroin addicts receiving methadone maintenance treatment. ( Adelson, M; Defrin, R; Hetzroni, T; Peles, E; Schreiber, S, 2011) |
"This observational study aimed to determine whether pain sensitivity in patients with noncancer chronic pain, taking either methadone or morphine, is similar to patients maintained on methadone for dependence therapy, compared with a control group." | 3.75 | Hyperalgesia in opioid-managed chronic pain and opioid-dependent patients. ( Bochner, F; Hay, JL; Rounsefell, B; Semple, TJ; Somogyi, AA; White, JM, 2009) |
" Chronic intrathecal morphine or methadone significantly increased spinal glial activation (toll-like receptor 4 mRNA and protein) and the expression of multiple chemokines and cytokines, combined with development of analgesic tolerance and pain enhancement (hyperalgesia, allodynia)." | 3.74 | Proinflammatory cytokines oppose opioid-induced acute and chronic analgesia. ( Baker, EM; Coats, BD; Hutchinson, MR; Jekich, BM; Judd, CM; Lewis, SS; Maier, SF; Martin, D; Poole, S; Rezvani, N; Somogyi, AA; Sprunger, DB; Watkins, LR; Wieseler, JL; Zhang, Y, 2008) |
"Hyperalgesia and allodynia in 4 cancer patients treated with morphine disappeared after discontinuing or substituting morphine with other opioid agonists." | 3.69 | Disappearance of morphine-induced hyperalgesia after discontinuing or substituting morphine with other opioid agonists. ( Jensen, NH; Jensen, TS; Sjøgren, P, 1994) |
"Interestingly, opioids induce hyperalgesia via many of the same neuro-inflammatory and central sensitization processes that occur with the development of neuropathic pain." | 2.75 | Gabapentin improves cold-pressor pain responses in methadone-maintained patients. ( Compton, P; Kehoe, P; Ling, W; Sinha, K; Torrington, MA, 2010) |
"Methadone patients were tested over an inter-dosing period: at the time of trough plasma methadone concentration (0 h), and 3 h after their daily dose." | 2.70 | Hyperalgesic responses in methadone maintenance patients. ( Ali, R; Bochner, F; Doverty, M; Ling, W; Somogyi, AA; White, JM, 2001) |
"Methadone patients were hyperalgesic to pain induced by CP but not ES." | 2.70 | Methadone maintenance patients are cross-tolerant to the antinociceptive effects of morphine. ( Beare, CH; Bochner, F; Doverty, M; Ling, W; Menelaou, A; Somogyi, AA; White, JM, 2001) |
"Pharmacological approaches incorporate the continuation of usual medications (or equivalent), short-term use of sometimes much higher than average doses of additional opioid, and prescription of non-opioid and adjuvant drugs, aiming to improve pain relief and attenuate opioid tolerance and/or opioid-induced hyperalgesia." | 2.47 | Acute pain management in opioid-tolerant patients: a growing challenge. ( Huxtable, CA; MacIntyre, PE; Roberts, LJ; Somogyi, AA, 2011) |
"Opioid-induced hyperalgesia was associated with an increase in the MAC in normal rats who had not undergone surgery." | 1.42 | Hyperalgesia and increased sevoflurane minimum alveolar concentration induced by opioids in the rat: a randomised experimental study. ( Abreu, M; Aguado, D; Benito, J; García-Fernández, J; Segura, IA, 2015) |
"Methadone is an atypical opioid that inhibits hyperalgesia through NMDA-blockade, especially at low doses." | 1.39 | The use of very-low-dose methadone for palliative pain control and the prevention of opioid hyperalgesia. ( Bruera, E; Buckley, JS; Salpeter, SR, 2013) |
"Methadone only treated rats had a mean paw withdrawal latency significantly lower than the corresponding values for saline on days 8, 9, 10, 11, 12, 14, and 17 (P<0." | 1.36 | Model of methadone-induced hyperalgesia in rats and effect of memantine. ( Hay, JL; Irvine, R; Kaboutari, J; Salem, A; White, JM, 2010) |
"The degree of hyperalgesia was greater with l-methadone compared with d,l-methadone." | 1.34 | Characterization of the antinociceptive and pronociceptive effects of methadone in rats. ( Holtman, JR; Wala, EP, 2007) |
" Equally important perioperative treatment principles are stabilization of physical dependence by substitution with methadone (for heroin addicts) or benzodiazepines/clonidine (for alcohol, sedatives and hypnotics addiction), avoidance of stress and craving, thorough intraoperative and postoperative stress relief by using regional techniques or systematically higher than normal dosages of anesthetics and opioids, strict avoidance of inadequate dosage of analgetics, postoperative optimization of regional or systemic analgesia by non-opioids and coanalgetics and consideration of the complex physical and psychological characteristics and comorbidities." | 1.33 | [Anesthesia and analgesia in addicts: basis for establishing a standard operating procedure]. ( Heid, F; Jage, J, 2006) |
"Central to both pain responses and opioid addiction is activity at the micro -opioid receptor." | 1.32 | Association between human mu-opioid receptor gene polymorphism, pain tolerance, and opioid addiction. ( Alarcón, M; Compton, P; Geschwind, DH, 2003) |
"This hyperalgesia is evident in people with a history of heroin use and is not modified by methadone or buprenorphine treatment but is reduced by long-term abstinence from opioids." | 1.32 | Pleasure into pain: the consequences of long-term opioid use. ( White, JM, 2004) |
" to mice on an escalating three times per day dosing schedule resulted in a nearly 3-fold increase in the tail-flick ED50 dose of morphine which was prevented by s." | 1.30 | d-Methadone blocks morphine tolerance and N-methyl-D-aspartate-induced hyperalgesia. ( Davis, AM; Inturrisi, CE, 1999) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (5.56) | 18.2507 |
2000's | 19 (52.78) | 29.6817 |
2010's | 15 (41.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Larsen, IM | 1 |
Drewes, AM | 1 |
Olesen, AE | 1 |
Athanasos, P | 1 |
Ling, W | 5 |
Bochner, F | 4 |
White, JM | 6 |
Somogyi, AA | 7 |
Martin, DP | 1 |
Samora, WP | 1 |
Beebe, AC | 1 |
Klamar, J | 1 |
Gill, L | 1 |
Bhalla, T | 1 |
Veneziano, G | 1 |
Thung, A | 1 |
Tumin, D | 1 |
Barry, N | 1 |
Rice, J | 1 |
Tobias, JD | 1 |
Barelli, R | 1 |
Morelli Sbarra, G | 1 |
Sbaraglia, F | 1 |
Zappia, L | 1 |
Rossi, M | 1 |
Lamberts, JT | 1 |
Smith, CE | 1 |
Li, MH | 1 |
Ingram, SL | 1 |
Neubig, RR | 1 |
Traynor, JR | 1 |
Salpeter, SR | 2 |
Buckley, JS | 2 |
Bruera, E | 2 |
Craig, DS | 1 |
Aoki, Y | 1 |
Mizoguchi, H | 1 |
Watanabe, C | 1 |
Sakurada, T | 1 |
Sakurada, S | 1 |
Abreu, M | 1 |
Aguado, D | 1 |
Benito, J | 1 |
García-Fernández, J | 1 |
Segura, IA | 1 |
Compton, PA | 1 |
Torrington, MA | 2 |
Hutchinson, MR | 2 |
Coats, BD | 2 |
Lewis, SS | 2 |
Zhang, Y | 2 |
Sprunger, DB | 1 |
Rezvani, N | 2 |
Baker, EM | 1 |
Jekich, BM | 1 |
Wieseler, JL | 2 |
Martin, D | 1 |
Poole, S | 1 |
Judd, CM | 1 |
Maier, SF | 2 |
Watkins, LR | 2 |
Prommer, EE | 1 |
Hay, JL | 2 |
Semple, TJ | 1 |
Rounsefell, B | 1 |
Kaboutari, J | 1 |
Salem, A | 1 |
Irvine, R | 1 |
Compton, P | 2 |
Kehoe, P | 1 |
Sinha, K | 1 |
Yin, H | 1 |
Rice, KC | 1 |
Peles, E | 1 |
Schreiber, S | 1 |
Hetzroni, T | 1 |
Adelson, M | 1 |
Defrin, R | 1 |
Huxtable, CA | 1 |
Roberts, LJ | 1 |
MacIntyre, PE | 1 |
Clark, DJ | 1 |
Geschwind, DH | 1 |
Alarcón, M | 1 |
Drummond, PD | 1 |
de Silva-Rossdeutscher, E | 1 |
Chung, KS | 1 |
Carson, S | 1 |
Glassman, D | 1 |
Vadivelu, N | 1 |
Pérez Martínez, J | 1 |
Arguis Giménez, MJ | 1 |
Fernández Candil, JL | 1 |
Martínez Fernández, G | 1 |
Sinche Yupanqui, M | 1 |
Moreno Cuartas, LA | 1 |
Galard Hernández, JJ | 1 |
Gomar Sancho, C | 1 |
Streltzer, J | 1 |
Johansen, L | 1 |
Prommer, E | 1 |
Jage, J | 1 |
Heid, F | 1 |
Holtman, JR | 1 |
Wala, EP | 1 |
Davis, MP | 1 |
Shaiova, LA | 1 |
Angst, MS | 1 |
Prosser, JM | 1 |
Steinfeld, M | 1 |
Cohen, LJ | 1 |
Derbyshire, S | 1 |
Eisenberg, DP | 1 |
Cruciani, RA | 1 |
Galynker, II | 1 |
Sjøgren, P | 1 |
Jensen, NH | 1 |
Jensen, TS | 1 |
Davis, AM | 1 |
Inturrisi, CE | 1 |
Doverty, M | 2 |
Ali, R | 1 |
Beare, CH | 1 |
Menelaou, A | 1 |
Bulka, A | 1 |
Plesan, A | 1 |
Xu, XJ | 1 |
Wiesenfeld-Hallin, Z | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Analgesia Following Posterior Spinal Fusion: Methadone vs Magnesium[NCT01795495] | Phase 2 | 63 participants (Actual) | Interventional | 2013-09-30 | Completed | ||
A Prospective Study Comparing Total Intravenous Anesthesia With Propofol and Remifentanil vs. Propofol and Dexmedetomidine in Adolescent Idiopathic Scoliosis Patients Undergoing Posterior Spinal Fusion and Instrumentation[NCT06096181] | Phase 2 | 120 participants (Anticipated) | Interventional | 2023-12-31 | Not yet recruiting | ||
Opioid-Induced Hyperalgesia in Prescription Opioid Abusers: Effects of Pregabalin[NCT01821430] | Phase 2 | 4 participants (Actual) | Interventional | 2013-03-31 | Terminated (stopped due to poor recruitment) | ||
Effect of Opioid Taper on Pain Responses in Patients With Chronic Pain[NCT03912298] | 7 participants (Actual) | Observational | 2019-04-15 | Completed | |||
A Double Blind, Randomized Clinical Trial Comparing Postoperative Narcotic Usage in Patients Receiving Periarticular Liposomal Bupivicaine vs. Those Patients Receiving Standard Periarticular Joint Injections[NCT02682498] | Phase 4 | 38 participants (Actual) | Interventional | 2013-10-31 | Completed | ||
IRB-HSR# 14145 R,S Methadone: Analgesia and Pharmacokinetics in Adolescents Undergoing Scoliosis Correction[NCT01205256] | Phase 3 | 11 participants (Actual) | Interventional | 2009-03-31 | Completed | ||
The Effect of Methadone vs. Fentanyl Administration on Postoperative Pain Control in Pediatric Patients Undergoing Cardiac Surgery: A Randomized, Double-Blinded Controlled Trial[NCT02747875] | 26 participants (Actual) | Interventional | 2016-09-30 | Terminated (stopped due to Drug Shortage) | |||
The Effects of Opioid Taper on Opioid-Induced Hyperalgesia[NCT03063905] | 15 participants (Actual) | Observational | 2017-01-31 | Terminated (stopped due to funding expired) | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
To prospectively compare the effects of intra-operative methadone and magnesium on postoperative opioid requirements. Total amount of hydromorphone administered in OR, recovery room (PACU), and on the inpatient ward 24 hours post-operatively. (NCT01795495)
Timeframe: Intra-operative and 24 hours post-operatively
Intervention | mg/kg (Mean) |
---|---|
Remifentanil | 0.34 |
Remifentanil Plus Methadone | 0.26 |
Remifentanil Plus Magnesium | 0.38 |
VAS pain score - 0 being no pain and 10 being worst pain. (NCT01795495)
Timeframe: Post-operatively to 24 hours
Intervention | units on a scale (Mean) |
---|---|
Remifentanil | 4.6 |
Remifentanil Plus Methadone | 5.1 |
Remifentanil Plus Magnesium | 5.1 |
Conditioned pain modulation will be measured using the quantitative sensory testing (QST) employing procedures consistent with those described in the literature to capture supra-spinal mechanisms of OIH. To detect conditioned modulation, the subject is asked to verbally report the severity of pain experienced on a visual analogue scale (0- no pain, 10-worst pain ever) to a three-second painful heat stimulus (47○C) delivered at 12-15 second intervals, in the presence or absence of the non-dominant limb being immerged in a cold-water bath (12○C). The reported value is the difference between the average of pain scores reported in the absence of vs. the presence of the counter-stimulation. Reported are changes in the conditioned pain modulation assay both prior to and following taper. Taper is individualized thus length of taper varies between subjects. (NCT03912298)
Timeframe: up to one year (individualized, variable taper length)
Intervention | units on a visual analogue scale (Mean) | |
---|---|---|
pre-taper conditioned pain modulation (baseline) | post taper conditioned pain modulation (individualized taper, thus time length varies) | |
Chronic Pain Patients Undergoing Opioid Taper | -0.14 | -0.40 |
Pain perception will be measured using the cold-pressor test (CPT) employing procedures consistent with those described in the literature. Order of pain testing will vary, and three aspects of the pain response will be captured at each study session: evoked pain; temporal summation; and conditioned pain modulation, which map on to the hypothesized peripheral, spinal and supra-spinal mechanisms of OIH. Reported are cold-pressor pain tolerance prior to and following taper. (NCT03912298)
Timeframe: up to one year (length of taper individualized and varies)
Intervention | seconds (Mean) | |
---|---|---|
pre taper pain tolerance (baseline) | post-taper pain tolerance (timeframe variable) | |
Chronic Pain Patients Undergoing Opioid Taper | 24.01 | 42.02 |
A comparison of group means between the control group and study group with regards to 48 hour opioid use. (NCT02682498)
Timeframe: 48 hours
Intervention | morphine equivalents (Mean) |
---|---|
EXPAREL® Bupivacaine Liposome Suspension | 5.32 |
Standard Periarticular Joint Injection | 5.07 |
Opioid use will be monitored daily from the time of admission in comparison of standard knee injection post-operatively. (NCT02682498)
Timeframe: Up to 48 hours
Intervention | Total Morphine Equivalents (Mean) |
---|---|
EXPAREL® Bupivacaine Liposome Suspension | 100 |
Standard Periarticular Joint Injection | 103 |
Examining the average daily patient pain score in comparison of standard knee injection post-operatively. The measure is the Visual-Analog-Scale (VAS) for subjective pain reporting. The minimum 0 (no pain) and the maximum is 10 (worst pain imagineable). There is only one measure in the scale (i.e. there are no subscales). Lower scores on the VAS scale equate to less pain and are therefore desirable. (NCT02682498)
Timeframe: Up to 48 hours
Intervention | Visual Analog Scale Rating (Mean) |
---|---|
EXPAREL® Bupivacaine Liposome Suspension | 4.75 |
Standard Periarticular Joint Injection | 5.75 |
Examining the post-operative complication in comparison of standard knee injection post-operatively. (NCT02682498)
Timeframe: Up to 1 month
Intervention | complications (Number) |
---|---|
EXPAREL® Bupivacaine Liposome Suspension | 0 |
Standard Periarticular Joint Injection | 0 |
Post anesthesia care unit (recovery room) opioid use in total mg morphine IV equivalent in comparison of standard knee injection post-operatively. (NCT02682498)
Timeframe: Up to 48 hours
Intervention | Total morphine equivalents (Median) |
---|---|
EXPAREL® Bupivacaine Liposome Suspension | 5 |
Standard Periarticular Joint Injection | 5 |
The distribution of the total opioid dose in the first 24 hours will be evaluated by randomization group (methadone vs. fentanyl) and differences between groups will be tested. It is hypothesized that compared to fentanyl, methadone administered intraoperative will result in a significantly lower total opioid dose (morphine or oxycodone) during the first 24 hour postoperative period. Assuming no difference between the two treatment strategies in the population, a total sample size of 52 in each group will provide 80% power to detect an effect size of 0.1. Significance will be measured as a 30% reduction in postoperative pain requirement. (NCT02747875)
Timeframe: 24 hours
Intervention | mg postop morphine equivelant 24hr (Mean) |
---|---|
Control - Fentanyl | 0.55 |
Treatment - Methadone | 0.48 |
Opioid-related adverse events will be monitored closely and a secondary analysis will compare the incidence of side effects between the two groups during the first 24-hour postoperative period. The Pearson's contingency chi-square test will be used to evaluate any differences between the randomization groups in opioid-related adverse events during the first 24-hour postoperative period. (NCT02747875)
Timeframe: 24 hours
Intervention | events (Mean) | |||
---|---|---|---|---|
Ondansetron Doses | Emesis Episodes | Hypoventilation Episodes | Arrhythmias | |
Control - Fentanyl | 3.81 | 2.72 | 0 | 0 |
Treatment - Methadone | 3.43 | 2.08 | 0 | 0 |
1 review available for methadone and Allodynia
Article | Year |
---|---|
Acute pain management in opioid-tolerant patients: a growing challenge.
Topics: Acute Disease; Analgesics; Analgesics, Opioid; Animals; Australia; Buprenorphine; Buprenorphine, Nal | 2011 |
7 trials available for methadone and Allodynia
Article | Year |
---|---|
The Effect of a Combination of Diclofenac and Methadone Applied as Gel in a Human Experimental Pain Model - A Randomized, Placebo-controlled Trial.
Topics: Administration, Cutaneous; Adult; Capsaicin; Chronic Pain; Cross-Over Studies; Diclofenac; Dose-Resp | 2018 |
Analgesic effects of methadone and magnesium following posterior spinal fusion for idiopathic scoliosis in adolescents: a randomized controlled trial.
Topics: Adolescent; Analgesics, Opioid; Desflurane; Female; Humans; Hyperalgesia; Magnesium; Male; Methadone | 2018 |
Lack of effect of chronic dextromethorphan on experimental pain tolerance in methadone-maintained patients.
Topics: Adolescent; Adult; Analgesics, Opioid; Dextromethorphan; Double-Blind Method; Excitatory Amino Acid | 2008 |
Gabapentin improves cold-pressor pain responses in methadone-maintained patients.
Topics: Adult; Amines; Analgesics, Non-Narcotic; Cold Temperature; Cyclohexanecarboxylic Acids; Double-Blind | 2010 |
Transcutaneous iontophoresis of methadone provokes local flushing and thermal hyperalgesia.
Topics: Administration, Cutaneous; Adolescent; Adult; Female; Flushing; Hot Temperature; Humans; Hyperalgesi | 2003 |
Hyperalgesic responses in methadone maintenance patients.
Topics: Adult; Cold Temperature; Confidence Intervals; Electric Stimulation; Female; Humans; Hyperalgesia; M | 2001 |
Methadone maintenance patients are cross-tolerant to the antinociceptive effects of morphine.
Topics: Acute Disease; Adult; Analgesics, Opioid; Cold Temperature; Drug Interactions; Drug Tolerance; Elect | 2001 |
28 other studies available for methadone and Allodynia
Article | Year |
---|---|
Buprenorphine Maintenance Subjects Are Hyperalgesic and Have No Antinociceptive Response to a Very High Morphine Dose.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Drug Tolerance; Female; Humans; Hyperalgesia; Injections, | 2019 |
Prevention of post-operative hyperalgesia in a heroin-addicted patient on methadone maintenance.
Topics: Analgesics, Opioid; Heroin; Humans; Hyperalgesia; Ketamine; Male; Methadone; Middle Aged; Opioid-Rel | 2019 |
Differential control of opioid antinociception to thermal stimuli in a knock-in mouse expressing regulator of G-protein signaling-insensitive Gαo protein.
Topics: Analgesics, Opioid; Animals; Brain; Diprenorphine; Dose-Response Relationship, Drug; Electric Stimul | 2013 |
The use of very-low-dose methadone for palliative pain control and the prevention of opioid hyperalgesia.
Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; California; Dose-Response Relationship, Drug; Ex | 2013 |
Very-low-dose methadone: authors' response.
Topics: Analgesics, Opioid; Dose-Response Relationship, Drug; Female; Hospice Care; Humans; Hyperalgesia; Ma | 2013 |
Very-low-dose methadone for the prevention of opioid hyperalgesia.
Topics: Analgesics, Opioid; Dose-Response Relationship, Drug; Female; Hospice Care; Humans; Hyperalgesia; Ma | 2013 |
Differential alternation of the antinociceptive effect of narcotic analgesics on the inflammatory pain state.
Topics: Animals; Fentanyl; Freund's Adjuvant; Hyperalgesia; Inflammation; Male; Methadone; Mice; Narcotics; | 2014 |
Hyperalgesia and increased sevoflurane minimum alveolar concentration induced by opioids in the rat: a randomised experimental study.
Topics: Analgesics, Opioid; Anesthetics, Inhalation; Animals; Behavior, Animal; Buprenorphine; Hyperalgesia; | 2015 |
Proinflammatory cytokines oppose opioid-induced acute and chronic analgesia.
Topics: Analgesia; Analgesics, Opioid; Animals; Catheters, Indwelling; Chemokine CX3CL1; Cytokines; Hyperalg | 2008 |
Opioid-induced pain.
Topics: Analgesics, Opioid; Animals; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; | 2008 |
Hyperalgesia in opioid-managed chronic pain and opioid-dependent patients.
Topics: Adult; Analgesics, Opioid; Chronic Disease; Drug Tolerance; Female; Humans; Hyperalgesia; Male; Meth | 2009 |
Model of methadone-induced hyperalgesia in rats and effect of memantine.
Topics: Animals; Behavior, Animal; Disease Models, Animal; Hyperalgesia; Male; Memantine; Methadone; Rats; R | 2010 |
Possible involvement of toll-like receptor 4/myeloid differentiation factor-2 activity of opioid inactive isomers causes spinal proinflammation and related behavioral consequences.
Topics: Analgesics, Opioid; Animals; Gliosis; Hyperalgesia; Immunity, Innate; Inflammation; Inflammation Med | 2010 |
The differential effect of methadone dose and of chronic pain on pain perception of former heroin addicts receiving methadone maintenance treatment.
Topics: Adult; Analgesics, Opioid; Analysis of Variance; Chronic Disease; Dose-Response Relationship, Drug; | 2011 |
Comment on: Doverty et al, Hyperalgesic responses in methadone maintenance patients (Pain 2001;90;91-6).
Topics: Animals; Humans; Hyperalgesia; Methadone; Opioid-Related Disorders; Pain Threshold; Patients | 2002 |
Association between human mu-opioid receptor gene polymorphism, pain tolerance, and opioid addiction.
Topics: Humans; Hyperalgesia; Methadone; Opioid-Related Disorders; Polymorphism, Genetic; Receptors, Opioid, | 2003 |
Pleasure into pain: the consequences of long-term opioid use.
Topics: Analgesics, Opioid; Drug Tolerance; Humans; Hyperalgesia; Methadone; Mood Disorders; Narcotics; Sens | 2004 |
Successful treatment of hydromorphone-induced neurotoxicity and hyperalgesia.
Topics: Humans; Hydromorphone; Hyperalgesia; Male; Methadone; Middle Aged; Narcotics; Neurotoxicity Syndrome | 2004 |
[Intrathecal methadone for cancer pain after vulvectomy].
Topics: Analgesics, Opioid; Carcinoma; Combined Modality Therapy; Female; Humans; Hyperalgesia; Hysterectomy | 2004 |
Prescription drug dependence and evolving beliefs about chronic pain management.
Topics: Adult; Analgesics, Opioid; Chronic Disease; Drug Prescriptions; Drug Tolerance; Drug Utilization; Fe | 2006 |
Rotating methadone to other opioids: a lesson in the mechanisms of opioid tolerance and opioid-induced pain.
Topics: Adult; Drug Tolerance; Humans; Hyperalgesia; Male; Methadone; Narcotics; Pain; Receptors, N-Methyl-D | 2006 |
[Anesthesia and analgesia in addicts: basis for establishing a standard operating procedure].
Topics: Analgesics; Analgesics, Opioid; Anesthesia; Diagnosis, Dual (Psychiatry); Drug Tolerance; Humans; Hy | 2006 |
Characterization of the antinociceptive and pronociceptive effects of methadone in rats.
Topics: Analgesics, Opioid; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Hot T | 2007 |
Characterization of the antinociceptive and pronociceptive effects of methadone in rats.
Topics: Analgesics, Opioid; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Hot T | 2007 |
Characterization of the antinociceptive and pronociceptive effects of methadone in rats.
Topics: Analgesics, Opioid; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Hot T | 2007 |
Characterization of the antinociceptive and pronociceptive effects of methadone in rats.
Topics: Analgesics, Opioid; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Hot T | 2007 |
When opioids cause pain.
Topics: Analgesics, Opioid; Back Pain; Carcinoma, Hepatocellular; Drug Therapy, Combination; Fentanyl; Human | 2007 |
Abnormal heat and pain perception in remitted heroin dependence months after detoxification from methadone-maintenance.
Topics: Adult; Demography; Diagnostic and Statistical Manual of Mental Disorders; Differential Threshold; Fe | 2008 |
Disappearance of morphine-induced hyperalgesia after discontinuing or substituting morphine with other opioid agonists.
Topics: Adult; Aged; Analgesics, Opioid; Child; Delayed-Action Preparations; Female; Humans; Hyperalgesia; M | 1994 |
d-Methadone blocks morphine tolerance and N-methyl-D-aspartate-induced hyperalgesia.
Topics: Analgesics, Opioid; Animals; Dose-Response Relationship, Drug; Drug Tolerance; Excitatory Amino Acid | 1999 |
d-Methadone blocks morphine tolerance and N-methyl-D-aspartate-induced hyperalgesia.
Topics: Analgesics, Opioid; Animals; Dose-Response Relationship, Drug; Drug Tolerance; Excitatory Amino Acid | 1999 |
d-Methadone blocks morphine tolerance and N-methyl-D-aspartate-induced hyperalgesia.
Topics: Analgesics, Opioid; Animals; Dose-Response Relationship, Drug; Drug Tolerance; Excitatory Amino Acid | 1999 |
d-Methadone blocks morphine tolerance and N-methyl-D-aspartate-induced hyperalgesia.
Topics: Analgesics, Opioid; Animals; Dose-Response Relationship, Drug; Drug Tolerance; Excitatory Amino Acid | 1999 |
Reduced tolerance to the anti-hyperalgesic effect of methadone in comparison to morphine in a rat model of mononeuropathy.
Topics: Analgesics, Opioid; Animals; Disease Models, Animal; Drug Tolerance; Hyperalgesia; Male; Methadone; | 2002 |